Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSOLUTIONStandard

ARMLUPEG

PEGFILGRASTIM-UNNE

Standard Dose
6MG/0.6ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ARMLUPEG is listed in Drugs@FDA under application 761212 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PEGFILGRASTIM-UNNE Form and strength INJECTION;SOLUTION - 6MG/0.6ML Sponsor LUPIN LTD Submission history Latest submission status date: 2025-11-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview ARMLUPEG is listed in Drugs@FDA under application 761212 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient PEGFILGRASTIM-UNNE Form and strength INJECTION;SOLUTION - 6MG/0.6ML Sponsor LUPIN LTD Submission history Latest submission status date: 2025-11-28 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.